Studies on drug release in vitro and absorption in rat in vivo of ginsenoside Rd solid lipid nanoparticles

Chinese Pharmacological Bulletin

Volumn 25, Issue 7, 2009, Pages

  Luo, De Feng ^a   Ye, Jian Tao ^a   Zhang, Yi Shan ^a   Liu, De Yu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Drug release in vitro; Ginsenoside Rd; Intestinal absorption; Pharmacokinetics; Plasma concentration; Solid lipid nanoparticles

Indexed keywords

GINSENOSIDE RD; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DUODENUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INTESTINE ABSORPTION; JEJUNUM; NONHUMAN; PERFUSION; RAT; SUSTAINED DRUG RELEASE;

EID: 70350289746     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. 2[J]. Chin Pharmacol Bull, 2007,23(8):1030-1034
2. Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectivesc[J]. Int J Nanomedicine, 2007,2(3):289-300. (Pubitemid 350047774)
3. Tian J, Pang X, Yu K, et al. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin [J]. Pharmazie, 2008,63(8):593-597
4. Liu D Y, Zeng S. A rapid and mass production method to extract ginsenoside Rd from notoginseng[J]. J Chin Med Mat,2006,29(3):247-249
5. Xi N, Hou L B, Wang C X, et al. Preparation and in vitro drug release behavior of hydroxycamptothecin semisolid lipid nanoparticles[J]. Chin Hosp Pharm J, 2007,27(2):139-142
6. Liu J P, Du Z Y, Zhu L. Studies on drug release in vitro and rat intestinal absorption of tashinone II A solid lipid nanoparticles[J]. Chin Pharmacol Bull, 2005,21(2):186-190 (Pubitemid 40524230)
7. Martins S, Sarmento B, Ferreira D C, et al. Lipid-based colloidal carriers for peptide and protein delivery-liposomes versus lipid nanoparticles[J]. Int J Nanomedicine, 2007,2(4):595-607.
8. Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism[J]. Eur J Pharm Biopharm, 1998,45(2):1492-1551 (Pubitemid 28167741)
9. Yang L, Deng Y, Xu S. In vivo pharmacokinetic and metabolism studies of ginsenoside Rd[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2007,854(1-2):77-84.
10. Zhang N, Ping Q, Huang G, et al. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin[J]. Int J Pharm, 2006,327(1-2):153-159 (Pubitemid 44667334)
11. Wu Q Z, Ping Q N. Studie's on the intestinal absorption site of insulin in stearic acid nanoparticles as cairrers[J]. J China Pharm Univ,2002,33(3):192- 195
12. Brüsewitz C, Schendler A, Funke A, et al. Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds[J]. Int J Pharm,2007,329(1-2):173-181
13. Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration[J]. J Control Release, 2005,107(2):215-228 (Pubitemid 41319672)